
16:20
Hey guys, can you hear me ok?

20:20
Dr. Ahuja is also here as lead Judge!

21:57
Judges- please put your questions in the chat

24:59
why would a CDA not fire?

25:49
was there any geographic patterns in patients that had a deterioration event with no CDA fire?

27:39
thanks all. have to head to shift but rob can answer more questions in his later discussion!

31:31
Were there any changes to the CMQCC guidelines for VTE based on the new published data?

32:36
1min

39:42
1min

40:03
Can this game be played in a mobile platform?

41:10
What was the time frame of the intervention? (Specifically, since SQ has existed since 2018, did Covid make it more popular, unchanged?)

41:54
would be great to assess knowledge retention on this group of learners…

44:45
I have to run to the OR but thank you everyone for your time. Wish I could listen in on more presentations.

47:13
1 min remaining

47:33
Is the reminder on Epic a BPA (best practice advisory?) that fired on patients that have been on steroids for more than 3 months? How is the Epic order set reminding physicians?

53:47
1min remaining

55:19
This work highlights the complexity of specialty pharmacy dispensing. Phase 3 is taking too long. Can you comment on the ‘low hanging fruits’ you have identified?

55:55
1min over time

56:05
Do you feel these 4 interventions are expandable to administration of many other medications and, if so, do you plan to scale?

56:45
Have the implemented interventions shown an impact of the waiting time for patients?

58:12
Hi Gida - can you put your responses in chat

59:26
My understanding was SHC does not have enough beds to do inpatient hospice which has been one of the big barriers. Can you comment on this?

59:53
Yes, the we expect the 4 interventions to impact other types of biologics. There are currently other biologics used for HS that are non-FDA approved but we chose to start with Humira because it is is FDAR approved. We also expect our findings to impact other patients with other conditions that require biologics such as asthma, crohn's etc

01:01:04
we are unable to assess whether the implemented interventions have had an impact yet mainly because there are very few patients who have been prescribed Humira recently. we only prescribe it for HS stage II/III. we will need more time and patients to assess these interventions. thank you

01:01:26
Thank you Ghida

01:02:09
Thank you Ghida. Very complex work glad you are shedding some light on this issue for our HS (and other Humira) patients.

01:02:41
1min remaining

01:04:48
1min over time

01:06:00
please wrap up - 7 min total

01:06:04
Yes, comfort care is now added to the patient's Storyboard and should be easier to identify. Comfort Care is also available in columns in patient's list. Should be easier to do this prospective review now Adi. You did a lot of work during these 2 weeks. Thanks!

01:06:53
Great that you included PAMF

01:07:23
I think it's a great idea. Next step is to further assess barriers to it's use I think

01:12:03
1min

01:13:22
Upon completion of this project, do you still believe all ED folks should be educated in this skill or that the optimal safety of the patient will be in the hands of a 'super user’?

01:14:00
The reality of ED training is lots of people need to be capable to practice in a place with no resources.

01:15:20
Thanks Nicole

01:20:22
1min remaining

01:21:09
amazing work on a vexing problem. thank you.

01:24:06
I think it has "legs”

01:24:28
thank you all!

01:24:31
great presetnations!

01:24:32
Thank you all and to Jenny for facilitating so effectively!

01:24:39
Thank you all !

01:25:31
https://stanforduniversity.qualtrics.com/jfe/form/SV_esSdXnEg4HAUeZ8

01:27:59
I'm going to hop off but I will make Dr. Shieh the host.

01:28:21
Thanks judges!

01:28:38
make neera the host